Sygnus Biotech Logo
TRIPCEE
Rx Only
Ready for 24-48h Central Dispatch
In Stock

TRIPCEE Clinical Monograph & Batch COA

Certified DCGI Formulation Literature (PDF)

Download
Cream & OintmentPrescription Required (Schedule Drug)

TRIPCEE

5.0(1 review)
Verified Quality Batch
Active Drug Composition

Clobetasol 0.05% w/w , Neomycin 0.1% w/w , Miconazole 2% w/w

WHO-GMP Certified Batch ManufacturingDCGI Approved Formulation100% BioavailableAlu-Alu Packaging

TRIPCEE (Clobetasol 0.05% w/w , Neomycin 0.1% w/w , Miconazole 2% w/w) is manufactured under strict WHO-GMP compliance for maximum bioavailability and therapeutic efficacy.

Dosage FormCream
Packaging Presentation20gm
B2B Distributor & Healthcare Professional Notice:This product is supplied solely through verified licensed pharmaceutical distributors, stockists, and institutional tenders. Online retail checkout for prescription formulations is legally restricted.

Clinical Pharmacology & Therapeutic Profile

Comprehensive therapeutic guidelines for medical practitioners and institutional procurement

Therapeutic Indications

Indicated for therapeutic management within specified clinical indications under qualified physician guidance.

Mechanism of Action (MOA)

The active pharmacological principles in TRIPCEE deliver targeted therapeutic action through standardized systemic bioavailability and verified pharmacodynamics.

Dosage & Posology

As directed by the registered medical practitioner. Strictly adhere to full course duration.

Safety & Precautions

Well tolerated under clinical supervision. Contraindicated in patients with hypersensitivity to active ingredients.

Storage Guidelines

Store in a cool place below 25°C. Do not freeze. Replace cap tightly after use.

WHO-GMP Certified Purity

Manufactured in state-of-the-art HVAC controlled cleanrooms with 100% active ingredient bio-potency and analytical batch testing.

Alu-Alu Moisture Barrier

Superior barrier protection against tropical humidity, preventing physical degradation and guaranteeing 24-month stability.

Exclusive District Monopoly

Strict PCD franchise monopoly allocation ensuring zero price competition and complete territory protection for our partners.

Technical Product Specifications

Therapeutic SegmentCream & Ointment
Dosage FormCream
Packaging Type20gm
Regulatory ScheduleSchedule H
Country of OriginIndia
Quality StandardWHO-GMP & ISO 9001:2015
Batch Analytical COASupplied with Trade Invoice

Active Medical Composition

TRIPCEE features Clobetasol 0.05% w/w , Neomycin 0.1% w/w , Miconazole 2% w/w prepared to high pharmaceutical purity standards.

Therapeutic ClassificationCream & Ointment
Regulatory ScheduleSchedule Drug (Prescription Only)

*Disclaimer: Formulations are intended solely for distribution to licensed practitioners, hospitals, and pharmacies. Dosage must adhere to medical advice.

Verified Practitioner & Distributor Feedback

Customer & Clinical Reviews

Real feedback from registered physicians, stockists, PCD franchise partners, and verified buyers.

5.0

Based on 1 verified review

5
1 (100%)
4
0 (0%)
3
0 (0%)
2
0 (0%)
1
0 (0%)
Verified Feedback
14 Jul 2026

Utilized across our multi-specialty for TRIPCEE

TRIPCEE has been utilized across our multi-specialty clinical practice, with clinical parameters showing consistent positive progression on follow-up. Each pack features clear regulatory details, crisp typography, and verifiable batch analytical records. A reliable product that our medical team recommends with complete clinical confidence.

Dr. Tarun Sengupta•Infectious Disease Specialist, Guwahati
Distributor Inquiries

Questions Regarding TRIPCEE

What is the therapeutic indication and composition of TRIPCEE?

TRIPCEE contains Clobetasol 0.05% w/w , Neomycin 0.1% w/w , Miconazole 2% w/w indicated for Indicated for therapeutic management within specified clinical indications under qualified physician guidance. as formulated by Sygnus Biotech.

What packaging presentations are available for TRIPCEE?

TRIPCEE is supplied in tamper-evident 15g / 30g Laminated Aluminum Barrier Tube, engineered with barrier foil protection to ensure a 24 to 36 month shelf life.

Is monopoly PCD franchise territory available for TRIPCEE?

Yes, Sygnus Biotech grants exclusive district-wise monopoly marketing rights for TRIPCEE along with promotional visual aids, product cards, and marketing support.

What is the regulatory schedule and minimum order quantity (MOQ)?

TRIPCEE is categorized as Schedule H with an introductory PCD franchise MOQ of 100 units per batch.

Related Formulations in Cream & Ointment

View all Cream & Ointment →
Cream & Ointment
VIVO+ GEL

VIVO+ GEL

Diclofenac Sodium 1% w/v + Linseed Oil 3% w/w + Methyl Salicylate 10% w/w +Capsaicin 0.025% w/w Menthol 5% w/w + Benzyl Alcohol 1% w/w

Pack:30gm
Cream & Ointment
OXIDINE TOOTH PASTE

OXIDINE TOOTH PASTE

Pottasium Nitrate + Sodium Monofluorophosphate + Triclosan

Pack:50gm
Cream & Ointment
ACNEGO ADVANCE CREAM

ACNEGO ADVANCE CREAM

Hydroquinone 2% w/w + Tretinoin 0.025% w/w + Mometasone Furoate 0.1% w/w

Pack:15gm
Cream & Ointment
VIVO GEL

VIVO GEL

Diclofenac Sodium 1% w/w + Linseed Oil 3% w/w + Menthol 5% w/w + Methyl Salicylate 10% w/w

Pack:30gm
Monopoly PCD Franchise

Apply for Exclusive Marketing Rights of TRIPCEE

Check vacant territory availability in your state or district. Enjoy full marketing kit support, visual aids, and guaranteed zero competitor supply.